Recent CDNA Stock Price | CDNA Stock Predictions | |
$8.07 | +48.70% |
$12.00 |
Recent CDNA Analyst Ratings Breakdown, Making CDNA Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.0 | 2.0 | 2.0 | 2.0 |
For the CDNA stock predictions from the analysts covering CareDx Inc, we have collected all of the individual CDNA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering CDNA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CDNA stock predictions may vary widely, another useful metric to consider is the median CDNA stock prediction, which represents the price at which half of the analysts
made CDNA stock predictions that were higher and half made CDNA stock predictions that were lower. This makes for a different take on the CDNA stock predictions out there, as compared to average or mean.
And that median across all the individual CDNA stock predictions was: $12.0 as of 2024-04-19.
The very highest of the CDNA stock predictions for one year price target was $15.0, while the very lowest of the CDNA stock predictions in the analyst group was
$9.0 (with a standard deviation of $2.236). Get the latest Zacks research report on CDNA — FREE
Find out: CDNA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ERII Stock Predictions
EME Stock Predictions
ROLL Stock Predictions
ECOM Stock Predictions
BBAR Stock Predictions
TZOO Stock Predictions
VERO Stock Predictions
WMGI Stock Predictions
KDNY Stock Predictions
|
|
Buy (3.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |